/PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will share new pooled efficacy and safety analyses from the.
Martha Hickey and colleagues argue that social and cultural attitudes contribute to the varied experience of menopause and that medicalisation fuels negative perceptions
Menopause is a natural event for half of humankind. The term “menopause” denotes the final menstrual period but is often used to describe the menopause transition, starting with changes in the menstrual cycle and finishing one year after the final menstrual period. While media attention in in the UK may give the impression that growing numbers of women are struggling to cope with menopausal symptoms and are seeking hormonal treatment,1 there is no universal experience and most women prefer not to take medication unless their symptoms are severe.2 In fact, socioeconomic status, education level, and social and cultural attitudes to menopause act with biological factors such as hormonal changes, smoking, diet, and body mass index to determine the experience of menopause, including the nature and severity of symptoms